Publications
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate. Proc Natl Acad Sci U S A. 2022 ;119(11):e2112008119.
. Animal Models of Hepatitis C Virus Infection. Cold Spring Harb Perspect Med. 2020 ;10(5).
. Animal Models Used in Hepatitis C Virus Research. Int J Mol Sci. 2020 ;21(11).
. Liver-expressed and limit hepatitis C virus cross-species transmission to mice. Sci Adv. 2020 ;6(45).
. Mouse Models for Studying HCV Vaccines and Therapeutic Antibodies. Methods Mol Biol. 2019 ;1911:481-503.
. Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis. J Hepatol. 2019 ;71(3):543-552.
. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. PLoS Pathog. 2018 ;14(3):e1006908.
. Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates. J Infect Dis. 2017 ;215(12):1824-1831.
. . Expanding the Host Range of Hepatitis C Virus through Viral Adaptation. mBio. 2016 ;7(6).
. In vivo models of hepatitis B and C virus infection. FEBS Lett. 2016 ;590(13):1987-99.
. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology. 2015 ;62(1):57-67.
.